CN101496860A - Chinese patent medicine for treating fracture - Google Patents
Chinese patent medicine for treating fracture Download PDFInfo
- Publication number
- CN101496860A CN101496860A CNA2008102498887A CN200810249888A CN101496860A CN 101496860 A CN101496860 A CN 101496860A CN A2008102498887 A CNA2008102498887 A CN A2008102498887A CN 200810249888 A CN200810249888 A CN 200810249888A CN 101496860 A CN101496860 A CN 101496860A
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- caulis
- fracture
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a Chinese patent drug for treating fracture, which is characterized in that the raw material drug comprises the following components in portion by weight: 2 to 8 portions of tender catchweed bedstraw herb, 1 to 5 portions of torricellia angulata, 1 to 5 portions of ground beetle, 5 to 10 portions of berghaan, 3 to 5 portions of achyranthis aspera, 3 to 5 portions of glechoma longituba, 1 to 5 portions of homalomena rhizoma, 5 to 10 portions of hippochaete ramosissima, 5 to 10 portions of bottle gourd palpus, 5 to 10 portions of albiziae chinensis, 5 to 10 portions of sambucus thunbergiana, 5 to 10 portions of erberry, 5 to 10 portions of river crab, 10 to 15 portions of bauhinia championi, 1 to 5 portions of spine date, 1 to 3 portions of flying centipede, 5 to 10 portions of atalantina buxifolia, and 10 to 15 portions of hedyotis hedyotidea. The Chinese patent drug is used for treating the fracture, has the advantages of short treatment course, remarkable curative effect, no relapse, no pain for a patient, no side effect, and low cost.
Description
Technical field:
The present invention relates to Chinese patent drug technique field, relate in particular to a kind of Chinese patent medicine for the treatment of fracture.
Background technology:
At present, fracture is a kind of common because of drawing the orthopaedic disease that wound causes, at present the Therapeutic Method of doctor trained in Western medicine has: Gypsum Fibrosum, wear fixing meanss such as draw point, steel plate, adopt Therapeutic Method such as fluid infusion, anti-inflammatory analgetic, the patient is not only painful big, and treatment time is long, patient's some months of need lying in bed, and side effect is bigger.It is main that the traditional Chinese medical science adopts external application more, and oral medicine is the Therapeutic Method of assisting, mostly medicine time long, it is slow to take effect, curative effect is very not remarkable, the patient suffering is big, side effect is many, the not very good and recurrence of cure rate, and easily stay sequela, patient economy burden is big.
Summary of the invention:
The object of the present invention is to provide a kind of dosage little, short treating period, evident in efficacy and do not recur, patient's no pain has no side effect, Chinese patent medicine of the treatment fracture that cost is low and preparation method thereof.
Purpose of the present invention can reach by following measure: a kind of Chinese patent medicine for the treatment of fracture, it is characterized in that calculating according to components by weight percent, crude drug consists of: crude drug consists of: 2-8 parts of Herba Galii Teneris, 1-5 parts of Radix seu folium Gaultheriae intermediae, 1-5 parts of eupolyphaga, 5-10 parts of Gallus jabouilleis, 3-5 parts of Radix Achyranthis, 3-5 parts of HUOXUEDAN, 1-5 parts of Rhizoma Homalomenaes, 5-10 parts of Herba Clinopodii Polycephalies, 5-10 parts of calabash palpuses, 5-10 parts in principal columns of a hall tree, 5-10 parts of Rhizoma seu Herba Elatostematis stewardiis, 5-10 parts of Ramulus Sambuci Williamsii, 5-10 parts of crabs, 10-15 parts of Caulis Bauhiniae Championii, 1-5 parts of Zizyphus jujuba, 1-3 parts of Caulis et Folium Pothi Repentiss, 5-10 parts of atalantia buxjfolia, 10-15 parts of Caulis et Folium hedyotis hedyotideaes.
In order further to realize purpose of the present invention, a kind of Chinese patent medicine for the treatment of fracture, it is characterized in that calculating according to components by weight percent, crude drug consists of 4-6 parts of Herba Galii Teneris, 2-4 parts of Radix seu folium Gaultheriae intermediae, 2-4 parts of eupolyphaga, 6-8 parts of Gallus jabouilleis, 3-5 parts of Radix Achyranthis, 3-5 parts of HUOXUEDAN, 2-4 parts of Rhizoma Homalomenaes, 6-8 parts of Herba Clinopodii Polycephalies, 6-8 parts of calabash palpuses, 6-8 parts in principal columns of a hall tree, 6-8 parts of Rhizoma seu Herba Elatostematis stewardiis, 6-8 parts of Ramulus Sambuci Williamsii, 6-8 parts of crabs, 11-13 parts of Caulis Bauhiniae Championii, 2-4 parts of Zizyphus jujuba, 1-3 parts of Caulis et Folium Pothi Repentiss, 6-8 parts of atalantia buxjfolia, 11-13 parts of Caulis et Folium hedyotis hedyotideaes.
The present invention adopts the following principles of formulating prescriptions: activating blood circulation to dissipate blood stasis, dredge the meridian passage, reducing swelling and alleviating pain, reunion of bone.
Be the effect of Chinese herbal medicine of the present invention below:
Herba Galii Teneri: cold nature, acrid in the mouth hardship.Clearing away damp-heat, dissipating blood stasis, detumescence, effective to traumatic injury.
Radix seu folium Gaultheriae intermediae: bitter in the mouth, suffering, little fiber crops, property are put down.Blood circulation promoting and blood stasis dispelling, is controlled fracture, traumatic injury at relieving rigidity of muscles and knitting bone.
Eupolyphaga: warm in nature, blood circulation promoting and blood stasis dispelling, control and sprain.
Gallus jabouillei: warm in nature, sweet in the mouth.Blood circulation promoting and blood stasis dispelling, enrich blood, bone and muscle strengthening.
Radix Achyranthis: property is flat, bitter in the mouth is sour.Blood circulation promoting and blood stasis dispelling, heat clearing away, control traumatic injury.
HUOXUEDAN: hot in nature, acrid in the mouth.Promoting blood circulation to remove blood stasis, antiinflammatory, granulation promoting long bone, control fracture.
Rhizoma Homalomenae: hot, warm, alleviating pain and detumescence, strengthening bone and muscle,
Herba Clinopodii Polycephali: sweet, little hardship, bone and muscle strengthening, granulation promoting.
The calabash palpus: sweet, warm, dephlogistication and promoting nuscle growth, blood stasis removing.
Principal columns of a hall tree: light, puckery.The convergence granulation promoting is controlled traumatic hemorrhage.
Rhizoma seu Herba Elatostematis stewardii: property is flat, bitter in the mouth.Promoting tissue regeneration by removing blood stasis, relaxing muscles and tendons and activating QI and blood in the collateral, bone and muscle strengthening cures mainly traumatic injury, synthetism.
Ramulus Sambuci Williamsii: property is flat, sweet-bitter flavor.Invigorate blood circulation, pain relieving, control bones and muscles pain, wound hemorrhage, promoting bone fracture healing.
Crab: warm in nature, blood circulation promoting and blood stasis dispelling, promoting bone regeneration.
Caulis Bauhiniae Championii: sweet, hot, flat.Eliminating stasis to stop pain, relieving rigidity of muscles and knitting bone.
Zizyphus jujuba: property is flat, sweet in the mouth.The solid bone of Shujin, promoting blood circulation to remove obstruction in the collateral.
Caulis et Folium Pothi Repentis: warm in nature, acrid in the mouth.Reducing swelling and alleviating pain is controlled traumatic injury.
Atalantia buxjfolia: hot, warm, the blood stasis removing pain relieving.Cure mainly and swell and ache, fracture.
Caulis et Folium hedyotis hedyotideae: sweet, light, bone and muscle strengthening, blood stasis removing granulation promoting.
The test example
(1) animal toxicity test
1, acute toxicity test:
Oral medication:
1. getting medicine 6g of the present invention adds water and grinds and to make full dose become the homogenate of 60ml standby.
2. get 20 of white mice (each 10 of male and female), every white mice is irritated stomach 2 times with above-mentioned standby homogenate every day, each 1.0ml, accumulated dose 2.0ml, observed 5 days, all healthy existence of white mice does not have any toxicity, through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group be zero difference relatively.
Conclusion: this product to the oral dosis tolerata of white mice more than 10g/kg.
2, accumulation toxicity test
1. getting medicine 10g of the present invention adds water and grinds and to make full dose become the homogenate of 100ml standby.
2. get 30 of rat (each 15 of male and female), divide three dosage groups, the rat picked at random is divided into three groups, every group 10 (male and female each 5), every of every day observed 30 days respectively with above-mentioned standby filtrate filling stomach 1.0ml, 0.5ml, 0.25ml, the all healthy existence of rat, do not have any toxicity, through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group be zero difference relatively.Substantially do not have in the body and accumulate, 30 days cumulant of rat is 15 times of dosis tolerata, and does not have in the rat body and accumulate.
Conclusion: Chinese patent medicine of the present invention proves the rat accumulation toxicity test, Chinese patent medicine of the present invention do not have accumulate, nontoxic, without any side effects.
(2) clinical trial:
The present invention is formulated by Chinese crude drug, is the oral medicine of controlling fracture, and the applicant has treated the patient of 108 examples so far with this medicine in January, 2005, patient age 11-79 year, 11-40 year 68 examples wherein, 40-60 year 38 examples, 2 examples more than 60 years old, the course of disease is the shortest 3 hours, the course of disease is the longest to be 2 years, and treatment time is the shortest 20 days, the longest 40 days, clinical efficacy is remarkable, now is reported as follows:
Clinical data:
Processing: Herba Galii Teneri, Radix seu folium Gaultheriae intermediae, eupolyphaga, Gallus jabouillei, Radix Achyranthis, HUOXUEDAN, Rhizoma Homalomenae, Herba Clinopodii Polycephali, calabash palpus, principal columns of a hall tree, Rhizoma seu Herba Elatostematis stewardii, Ramulus Sambuci Williamsii, crab, Caulis Bauhiniae Championii, Zizyphus jujuba, Caulis et Folium Pothi Repentis, atalantia buxjfolia, Caulis et Folium hedyotis hedyotideae all are ground into end, mix homogeneously.
Usage: get above-mentioned Chinese patent medicine 20g every day twice at every turn, take after mixing it with water with yellow wine, taking 7 days is a course of treatment.Avoid clothes Semen phaseoli radiati and mung bean products.
Data shows: 40 examples of sampling, and male's 20 examples wherein, women's 20 examples wherein mostly are fracture patient, and serious comminuted fracture patient is also arranged.
Parameters for observation on effect: observe the variation of conditions of patients, the elimination of disease and administration time;
Therapeutic evaluation:
Fracture can be movable after 10 days in medication, and what basic healing was checked in film making is effective; The activity of fracture energy can be participated in normal work life freely, and what make film the inspection healing is produce effects; Fracture is inactive, for invalid;
Sum up: above-mentioned sampling 40 examples, wherein effective 40 examples account for 100%; Produce effects 39 examples account for 97.5%; Invalid is 0.
Discuss: patients such as fracture, bone splits, comminuted fracture mostly are the disorganization that burst accident causes, untimely treatment easily stays sequela, bring great misery and trouble for the later work life of patient; The present invention has relaxing muscles and tendons and activating QI and blood in the collateral, and effects such as bone and muscle strengthening, eliminating stasis to stop pain, blood stasis removing granulation promoting, antiinflammatory cold expelling can reach mitigation to symptom in the short time, and fracture is had fabulous curative effect.
Model case:
1, Xin Chonghua, woman, 79 years old, Rizhao City Donggang District Huang Dun people from town.In in JIUYUE, 2005, fall down right finesse bone meal fragility fracture accidentally.Took medicine 7 days, and can take chopsticks to have a meal after 3 days, can do housework more easily after the week, recovery from illness after 1 month.
2, Tian Liangcai, man, 30 years old, Penglai City's gu people of standing erect, hoistman, in May, 2007, throw the 405 hospital's CT examination of garrisoning through Penglai City, right arm fracture, fracture of rib from crane, suggestion is operative treatment in hospital, and the patient several times asks about, and takes Chinese medicine of the present invention 14 days, recovery from illness after 20 days, formal working.
3, Wang Hao, man, 11 years old, the 3rd student of experimental primary school of Penglai City, play soccer in January, 2008 and classmate, mix down because of carelessness, cause the knee double fracture, the orthopaedics doctor of Penglai City People's Hospital suggestion was suspended schooling 1 year, operative treatment, the head of a family considers that child is little, and is afraid of to delay study, took Chinese medicine of the present invention 7 days, recovery from illness after 1 month.
4, Jiang Liwei, man, 64 years old, the northern Rhizoma Zingiberis Recens household in the Bei Gou of Penglai City town, in in August, 2008 by bike slippery when wet fall down accidentally, cause the clavicle comminuted fracture, the Chinese medicine of the present invention 7 days of taking medicine, arm can be lifted to head in 6 days, just can cut Fructus Vitis viniferae after 20 days, recovery from illness after 40 days.
The specific embodiment:
Below the specific embodiment of the present invention is elaborated:
Embodiment 1: accurately taking by weighing Herba Galii Teneri 2g, Radix seu folium Gaultheriae intermediae 1g, eupolyphaga 1g, Gallus jabouillei 5g, Radix Achyranthis 3g, HUOXUEDAN 3g, Rhizoma Homalomenae 1g, Herba Clinopodii Polycephali 5g, calabash must 5g, principal columns of a hall tree 5g, Rhizoma seu Herba Elatostematis stewardii 5g, Ramulus Sambuci Williamsii 5g, crab 5g, Caulis Bauhiniae Championii 10g, Zizyphus jujuba 1g, Caulis et Folium Pothi Repentis 1g, atalantia buxjfolia 5g, Caulis et Folium hedyotis hedyotideae 10g are ground into end and mix homogeneously, technology is made powder routinely, packs.
Embodiment 2: accurately taking by weighing Herba Galii Teneri 8g, Radix seu folium Gaultheriae intermediae 5g, eupolyphaga 5g, Gallus jabouillei 10g, Radix Achyranthis 5g, HUOXUEDAN 5g, Rhizoma Homalomenae 5g, Herba Clinopodii Polycephali 10g, calabash must 10g, principal columns of a hall tree 10g, Rhizoma seu Herba Elatostematis stewardii 10g, Ramulus Sambuci Williamsii 10g, crab 10g, Caulis Bauhiniae Championii 15g, Zizyphus jujuba 5g, Caulis et Folium Pothi Repentis 3g, atalantia buxjfolia 10g, Caulis et Folium hedyotis hedyotideae 15g are ground into end and mix homogeneously, technology is made powder routinely, packs.
Embodiment 3: accurately taking by weighing Herba Galii Teneri 4g, Radix seu folium Gaultheriae intermediae 2g, eupolyphaga 2g, Gallus jabouillei 6g, Radix Achyranthis 3, HUOXUEDAN 3g, Rhizoma Homalomenae 2g, Herba Clinopodii Polycephali 6g, calabash must 6g, principal columns of a hall tree 6g, Rhizoma seu Herba Elatostematis stewardii 6g, Ramulus Sambuci Williamsii 6g, crab 6g, Caulis Bauhiniae Championii 11g, Zizyphus jujuba 2g, Caulis et Folium Pothi Repentis 1g, atalantia buxjfolia 6g, Caulis et Folium hedyotis hedyotideae 11g are ground into end and mix homogeneously, technology is made powder routinely, packs.
Embodiment 4: accurately taking by weighing Herba Galii Teneri 6g, Radix seu folium Gaultheriae intermediae 4g, eupolyphaga 4g, Gallus jabouillei 8g, Radix Achyranthis 5g, HUOXUEDAN 5g, Rhizoma Homalomenae 4g, Herba Clinopodii Polycephali 8g, calabash must 8g, principal columns of a hall tree 8g, Rhizoma seu Herba Elatostematis stewardii 8g, Ramulus Sambuci Williamsii 8g, crab 8g, Caulis Bauhiniae Championii 13g, Zizyphus jujuba 4g, Caulis et Folium Pothi Repentis 3g, atalantia buxjfolia 8g, Caulis et Folium hedyotis hedyotideae 13g are ground into end and mix homogeneously, technology is made powder routinely, packs.
Embodiment 5: accurately taking by weighing Herba Galii Teneri 5g, Radix seu folium Gaultheriae intermediae 3g, eupolyphaga 3g, Gallus jabouillei 7g, Radix Achyranthis 4g, HUOXUEDAN 4g, Rhizoma Homalomenae 3g, Herba Clinopodii Polycephali 7g, calabash must 7g, principal columns of a hall tree 7g, Rhizoma seu Herba Elatostematis stewardii 7g, Ramulus Sambuci Williamsii 7g, crab 7g, Caulis Bauhiniae Championii 12g, Zizyphus jujuba 3g, Caulis et Folium Pothi Repentis 2g, atalantia buxjfolia 7g, Caulis et Folium hedyotis hedyotideae 12g are ground into end and mix homogeneously, technology is made powder routinely, packs.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of fracture, it is characterized in that calculating according to components by weight percent, crude drug consists of: 2-8 parts of Herba Galii Teneris, 1-5 parts of Radix seu folium Gaultheriae intermediae, 1-5 parts of eupolyphaga, 5-10 parts of Gallus jabouilleis, 3-5 parts of Radix Achyranthis, 3-5 parts of HUOXUEDAN, 1-5 parts of Rhizoma Homalomenaes, 5-10 parts of Herba Clinopodii Polycephalies, 5-10 parts of calabash palpuses, 5-10 parts in principal columns of a hall tree, 5-10 parts of Rhizoma seu Herba Elatostematis stewardiis, 5-10 parts of Ramulus Sambuci Williamsii, 5-10 parts of crabs, 10-15 parts of Caulis Bauhiniae Championii, 1-5 parts of Zizyphus jujuba, 1-3 parts of Caulis et Folium Pothi Repentiss, 5-10 parts of atalantia buxjfolia, 10-15 parts of Caulis et Folium hedyotis hedyotideaes.
2, a kind of Chinese patent medicine for the treatment of fracture, it is characterized in that calculating according to components by weight percent, crude drug consists of 4-6 parts of Herba Galii Teneris, 2-4 parts of Radix seu folium Gaultheriae intermediae, 2-4 parts of eupolyphaga, 6-8 parts of Gallus jabouilleis, 3-5 parts of Radix Achyranthis, 3-5 parts of HUOXUEDAN, 2-4 parts of Rhizoma Homalomenaes, 6-8 parts of Herba Clinopodii Polycephalies, 6-8 parts of calabash palpuses, 6-8 parts in principal columns of a hall tree, 6-8 parts of Rhizoma seu Herba Elatostematis stewardiis, 6-8 parts of Ramulus Sambuci Williamsii, 6-8 parts of crabs, 11-13 parts of Caulis Bauhiniae Championii, 2-4 parts of Zizyphus jujuba, 1-3 parts of Caulis et Folium Pothi Repentiss, 6-8 parts of atalantia buxjfolia, 11-13 parts of Caulis et Folium hedyotis hedyotideaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102498887A CN101496860B (en) | 2008-12-30 | 2008-12-30 | Chinese patent medicine for treating fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102498887A CN101496860B (en) | 2008-12-30 | 2008-12-30 | Chinese patent medicine for treating fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101496860A true CN101496860A (en) | 2009-08-05 |
| CN101496860B CN101496860B (en) | 2010-12-22 |
Family
ID=40944269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102498887A Expired - Fee Related CN101496860B (en) | 2008-12-30 | 2008-12-30 | Chinese patent medicine for treating fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101496860B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600272A (en) * | 2012-04-11 | 2012-07-25 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN102784338A (en) * | 2012-08-25 | 2012-11-21 | 辛德友 | Traditional Chinese medicine fumigating and washing lotion for treating joint function disorder after fracturing |
| CN103372091A (en) * | 2012-04-20 | 2013-10-30 | 谭学初 | Plaster and preparation method thereof |
| CN103690688A (en) * | 2013-12-24 | 2014-04-02 | 张志荣 | Miao medicinal fracture setting powder capable of avoiding amputation |
-
2008
- 2008-12-30 CN CN2008102498887A patent/CN101496860B/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600272A (en) * | 2012-04-11 | 2012-07-25 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN102600272B (en) * | 2012-04-11 | 2013-10-09 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN103372091A (en) * | 2012-04-20 | 2013-10-30 | 谭学初 | Plaster and preparation method thereof |
| CN102784338A (en) * | 2012-08-25 | 2012-11-21 | 辛德友 | Traditional Chinese medicine fumigating and washing lotion for treating joint function disorder after fracturing |
| CN103690688A (en) * | 2013-12-24 | 2014-04-02 | 张志荣 | Miao medicinal fracture setting powder capable of avoiding amputation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101496860B (en) | 2010-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091202B (en) | Traditional Chinese medicinal composition for treating fracture and preparation method thereof | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN102133337B (en) | Externally applied medicinal liquor for treating traumatic injury | |
| CN101496860B (en) | Chinese patent medicine for treating fracture | |
| CN102078527A (en) | Traditional Chinese medicine formula for treating urinary calculus | |
| CN103191347A (en) | Traditional Chinese medicine composition for treating gynecological inflammation | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN101897879A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN104491642A (en) | Foot bath powder for preventing and treating gout | |
| CN102125664B (en) | Chinese medicinal preparation for treating cervical spondylosis | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN103638116A (en) | Auxiliary natural compound traditional Chinese medicine for osteosynthesis | |
| CN101390981B (en) | Bone fracture traditional Chinese medicine | |
| CN104161805A (en) | Traditional Chinese medicine for treating femoral head necrosis, and preparation method thereof | |
| CN104524096B (en) | A kind ofly treat Chinese medicine preparation of deficiency of the liver and kidney dysmenorrhea and preparation method thereof | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN108785421A (en) | A kind of Chinese medicine preparation and its preparation method for treating fracture | |
| CN102552829A (en) | Chinese medicine for treating urinary calculus | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN101628065B (en) | Bone recovering pill for treating bone necrosis | |
| CN101085154A (en) | Traditional Chinese medicine composition for treating leukorrhagia and its preparation method | |
| CN101085318A (en) | Traditional Chinese medicine for treating nephrotic syndrome | |
| CN105106533A (en) | Traditional Chinese medicine composition for treating gestational gallstones | |
| CN101279019B (en) | Bone-knitting medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20111230 |